Last reviewed · How we verify

NCT07045350: DEXPRF-3M

Dexamethasone-PRF in Mandibular Third Molar Surgery: Effect on Pain, Edema, and Trismus (DEXPRF-3M)

Completed NA Last updated 1 July 2025
What this trial tests

NA trial testing Platelet-rich fibrin (PRF) in Impacted Mandibular Third Molar in 16 participants. Completed in 23 July 2024.

Timeline
20 July 2023
Primary endpoint
25 April 2024
23 July 2024

Quick facts

Lead sponsorCumhuriyet University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingquadruple
Primary purposetreatment
Enrollment16
Start date20 July 2023
Primary completion25 April 2024
Estimated completion23 July 2024
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Cumhuriyet University

Who can join

Adults 18 to 25, any sex, with Impacted Mandibular Third Molar. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Brief Summary This clinical trial investigates the effects of platelet-rich fibrin (PRF) derived from dexamethasone-enriched blood on postoperative recovery following the surgical extraction of impacted mandibular third molars (wisdom teeth). The study aims to determine whether the addition of dexamethasone, a potent anti-inflammatory medication, to the blood used for PRF preparation can reduce postoperative pain, swelling, and limited mouth opening (trismus) more effectively than standard PRF. The study is designed as a randomized, split-mouth, double-blind clinical trial involving 16 patients who require bilateral extraction of impacted lower third molars. Each patient receives both treatments: one extraction socket treated with standard PRF and the other with dexamethasone-enriched PRF. Postoperative outcomes including pain intensity, edema, trismus, and analgesic consumption are recorded and analyzed. The results of this study could offer a safer and more effective method for managing discomfort after wisdom tooth removal, potentially improving patient quality of life and reducing the need for additional medications.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Platelet-rich fibrin (PRF)

Trials testing the same drug.

Other recruiting trials for Impacted Mandibular Third Molar

Currently open trials in the same condition.

Other Cumhuriyet University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07045350.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing